National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Polynuclear iron(III)-oxyhydroxide (pn-FeOOH) (Velphoro™) is indicated for the control of serum phosphorus levels in adult chronic kidney disease (CKD) patients on haemodialysis (HD) or peritoneal dialysis (PD).

Rapid Review

Commenced Completed Outcome
12/09/2014 08/10/2014 Full Pharmacoeconomic Evaluation Not Recommended.